De-nest, handle and stopper filled glass vials in aseptic vaccine fill-finish
In GSK's sterile vaccine and biologic fill-finish operations, filled thin-walled glass vials must be de-nested from tubs/nests, transferred, and seated with elastomeric stoppers (and downstream crimp seals) within a Grade A aseptic environment. The objects are fragile, lightweight glass cylinders with variable fill, where glass-to-glass and glass-to-tooling contact causes chipping or microcracks, and the rubber stopper must be pressed to a precise seating depth to guarantee container-closure integrity. The task sits at the critical end of the line where any breakage, particulate generation, or partially seated stopper means a rejected unit and potential sterility/contamination breach. GSK runs two aseptic vial and two syringe facilities and has explicitly built flexibility and automated visual inspection into these lines to meet surging vaccine demand. It is hard for a robot because success depends on modulating grip and insertion force on a fragile, deformable-sealed object rather than on position alone. We identified this through our own research; we have not confirmed the specifics with the customer directly. This page is our researched read — a starting point for that conversation.
What the task is
RESEARCHED · our reconstructionIn GSK's sterile vaccine and biologic fill-finish operations, filled thin-walled glass vials must be de-nested from tubs/nests, transferred, and seated with elastomeric stoppers (and downstream crimp seals) within a Grade A aseptic environment. The objects are fragile, lightweight glass cylinders with variable fill, where glass-to-glass and glass-to-tooling contact causes chipping or microcracks, and the rubber stopper must be pressed to a precise seating depth to guarantee container-closure integrity. The task sits at the critical end of the line where any breakage, particulate generation, or partially seated stopper means a rejected unit and potential sterility/contamination breach. GSK runs two aseptic vial and two syringe facilities and has explicitly built flexibility and automated visual inspection into these lines to meet surging vaccine demand. It is hard for a robot because success depends on modulating grip and insertion force on a fragile, deformable-sealed object rather than on position alone.
Is this the actual task and sequence? What are the real tolerances, cycle rate, and reject criteria, and which steps are today's manual bottleneck? Answering these is what turns this from a researched signal into a validated use case.